ESC Premium Access

A life-time perspective on the effects of an early invasive compared with a non-invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome - the FRISC II 15 years follow-up

Congress Presentation

About the speaker

Professor Lars Wallentin

Uppsala University, Uppsala (Sweden)
18 presentations
1 follower

5 more presentations in this session

5-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents in unselected patients

Speaker: Mr E. Christiansen (Aarhus, DK)

Thumbnail

10-year follow-up of clinical outcomes in a randomized trial comparing routine invasive versus selective invasive management in patients with non ST-segment elevation acute coronary syndrome.

Speaker: Professor R. De Winter (Amsterdam, NL)

Thumbnail

Comparative Efficacy of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Diabetic Patients with Multivessel Coronary Artery Disease With or Without Renal Dysfunction

Speaker: Doctor U. Baber (New York, US)

Thumbnail

The effect of CABG by age in patients with heart failure: 10 year follow data from the STICHES study

Speaker: Professor E. Velazquez (New Haven, US)

Thumbnail

ABSORB Japan: 2-year clinical results from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs. metallic drug-eluting stent in de novo native coronary artery lesions

Speaker: Professor T. Kimura (Hirakata, JP)

Thumbnail

Access the full session

Clinical Trial Update Coronary artery disease

Speakers: Professor L. Wallentin, Mr E. Christiansen, Professor R. De Winter, Doctor U. Baber, Professor E. Velazquez...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb